To explore further the dark toxicity of encapsulated and crosslinked RB nanoparticles, breast and prostate cancer cells were incubated with different concentrations of RB nanoparticles (10, 25, and 50 μg/mL) for 24 h instead of 1 h, as in the previous experiments. Here, RB1 is linked to prostate carcinoma.